{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:55:54Z","timestamp":1777370154790,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"am","delay-in-days":325,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005623","name":"University of Tokushima","doi-asserted-by":"publisher","award":["JPMJSP2113"],"award-info":[{"award-number":["JPMJSP2113"]}],"id":[{"id":"10.13039\/501100005623","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007807","name":"Japan Science Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP24KJ1752"],"award-info":[{"award-number":["JP24KJ1752"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.xphs.2025.103881","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T14:37:50Z","timestamp":1750171070000},"page":"103881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Protein-bound cisplatin could exhibit an efficient antitumor effect in vivo"],"prefix":"10.1016","volume":"114","author":[{"given":"Nana Cristina Amorim","family":"Matsuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6247-7574","authenticated-orcid":false,"given":"Hidenori","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7792-2239","authenticated-orcid":false,"given":"Haruka","family":"Takata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1333-6465","authenticated-orcid":false,"given":"Tatsuhiro","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.xphs.2025.103881_bib0001","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23137241","article-title":"Can cisplatin therapy Be improved? Pathways that Can Be targeted","volume":"23","author":"Ali","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.xphs.2025.103881_bib0002","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s10157-024-02490-x","article-title":"An integrated view of cisplatin-induced nephrotoxicity, hepatotoxicity, and cardiotoxicity: characteristics, common molecular mechanisms, and current clinical management","volume":"28","author":"Oliveira","year":"2024","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.xphs.2025.103881_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115323","article-title":"Cisplatin in cancer treatment","volume":"206","author":"Romani","year":"2022","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"10.1016\/j.xphs.2025.103881_bib0004","article-title":"Comparison of the efficacy of Cisplatin\/Paclitaxel versus Carboplatin\/Paclitaxel in improving survival and quality of life in the advanced ovarian cancer patient population: a systematic review and meta-analysis of randomized control trials","volume":"15","author":"Mansoor","year":"2023","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.xphs.2025.103881_bib0005","article-title":"Cisplatin-based chemotherapy of Human cancers","volume":"11","author":"Brown","year":"2019","journal-title":"J Cancer Sci Ther"},{"issue":"1","key":"10.1016\/j.xphs.2025.103881_bib0006","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1186\/s12885-019-6233-9","article-title":"Incidence and risk factors for acute kidney injury in head and neck cancer patients treated with concurrent chemoradiation with high-dose cisplatin","volume":"19","author":"van der Vorst","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.xphs.2025.103881_bib0007","article-title":"Derivation and external validation of a simple risk score for predicting severe acute kidney injury after intravenous cisplatin: cohort study","volume":"384","author":"Gupta","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.xphs.2025.103881_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114045","article-title":"Cisplatin-induced ototoxicity: from signaling network to therapeutic targets","volume":"157","author":"Wang","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"10.1016\/j.xphs.2025.103881_bib0009","doi-asserted-by":"crossref","DOI":"10.3390\/ph14020104","article-title":"The protein-binding behavior of platinum anticancer drugs in blood revealed by mass spectrometry","volume":"14","author":"Wang","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"issue":"11","key":"10.1016\/j.xphs.2025.103881_bib0010","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1002\/cmdc.200800151","article-title":"Characterisation of cisplatin binding sites in human serum proteins using hyphenated multidimensional liquid chromatography and ESI tandem mass spectrometry","volume":"3","author":"Will","year":"2008","journal-title":"ChemMedChem"},{"issue":"7","key":"10.1016\/j.xphs.2025.103881_bib0011","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/bdd.2197","article-title":"Interaction of platinum agents, cisplatin, carboplatin and oxaliplatin against albumin in vivo rats and in vitro study using inductively coupled plasma-mass spectrometory","volume":"40","author":"Kato","year":"2019","journal-title":"Biopharm Drug Dispos"},{"issue":"7","key":"10.1016\/j.xphs.2025.103881_bib0012","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13071572","article-title":"Mechanisms of cisplatin-induced acute kidney injury: pathological Mechanisms, pharmacological interventions, and genetic mitigations","volume":"13","author":"McSweeney","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xphs.2025.103881_bib0013","article-title":"Albumin-bound Paclitaxel: worthy of further study in Sarcomas","volume":"12","author":"Tian","year":"2022","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.xphs.2025.103881_bib0014","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0009-2797(81)90009-0","article-title":"Renal toxicity studies of protein-bound platinum(cis)","volume":"35","author":"Cole","year":"1981","journal-title":"Chem Biol Interact"},{"issue":"1","key":"10.1016\/j.xphs.2025.103881_bib0015","first-page":"68","article-title":"Antitumor activity and toxicity of serum protein-bound platinum formed from cisplatin","volume":"76","author":"Takahashi","year":"1985","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.xphs.2025.103881_bib0016","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jconrel.2022.08.031","article-title":"Oral administration of sodium bicarbonate can enhance the therapeutic outcome of Doxil(R) via neutralizing the acidic tumor microenvironment","volume":"350","author":"Ando","year":"2022","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.xphs.2025.103881_bib0017","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41467-019-14131-z","article-title":"Blood-triggered generation of platinum nanoparticle functions as an anti-cancer agent","volume":"11","author":"Zeng","year":"2020","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.xphs.2025.103881_bib0018","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1634\/theoncologist.2016-0319","article-title":"A systematic review of strategies to prevent cisplatin-induced nephrotoxicity","volume":"22","author":"Crona","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.xphs.2025.103881_bib0019","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/bs.acr.2021.03.008","article-title":"Cisplatin chemotherapy and renal function","volume":"152","author":"Zhang","year":"2021","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.xphs.2025.103881_bib0020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.talanta.2013.05.016","article-title":"A novel method for speciation of Pt in human serum incubated with cisplatin, oxaliplatin and carboplatin by conjoint liquid chromatography on monolithic disks with UV and ICP-MS detection","volume":"116","author":"Martincic","year":"2013","journal-title":"Talanta"},{"issue":"11","key":"10.1016\/j.xphs.2025.103881_bib0021","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1074\/mcp.R200007-MCP200","article-title":"The human plasma proteome: history, character, and diagnostic prospects","volume":"1","author":"Anderson","year":"2002","journal-title":"Mol Cell Proteomics"},{"issue":"2","key":"10.1016\/j.xphs.2025.103881_bib0022","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0009-2797(80)90128-3","article-title":"Preparation and metabolism of a cisplatin\/serum protein complex","volume":"30","author":"Cole","year":"1980","journal-title":"Chem Biol Interact"},{"issue":"12 Pt 1","key":"10.1016\/j.xphs.2025.103881_bib0023","first-page":"6387","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res"},{"issue":"24","key":"10.1016\/j.xphs.2025.103881_bib0024","doi-asserted-by":"crossref","first-page":"7447","DOI":"10.7150\/thno.34883","article-title":"Secreted protein acidic and rich in cysteine mediates active targeting of human serum albumin in U87MG xenograft mouse models","volume":"9","author":"Park","year":"2019","journal-title":"Theranostics"},{"issue":"21","key":"10.1016\/j.xphs.2025.103881_bib0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21217932","article-title":"Efficacy and safety of Human serum albumin-cisplatin complex in U87MG xenograft mouse models","volume":"21","author":"Park","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.xphs.2025.103881_bib0026","first-page":"745","article-title":"Progress on the role and mechanism of MT1-MMP in tumor metastasis","volume":"44","author":"Hao","year":"2022","journal-title":"Yi Chuan"},{"issue":"5","key":"10.1016\/j.xphs.2025.103881_bib0027","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052514","article-title":"The tumor proteolytic landscape: a challenging frontier in cancer diagnosis and therapy","volume":"22","author":"Vizovisek","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.xphs.2025.103881_bib0028","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1039\/C7MT00271H","article-title":"On the toxicity and transport mechanisms of cisplatin in kidney tissues in comparison to a gold-based cytotoxic agent","volume":"9","author":"Spreckelmeyer","year":"2017","journal-title":"Metallomics"},{"key":"10.1016\/j.xphs.2025.103881_bib0029","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.redox.2014.01.010","article-title":"Redox regulation of protein damage in plasma","volume":"2","author":"Griffiths","year":"2014","journal-title":"Redox Biol"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925003338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925003338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T18:15:30Z","timestamp":1756404930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354925003338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0022354925003338"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103881","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protein-bound cisplatin could exhibit an efficient antitumor effect in vivo","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103881","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Pharmacists Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103881"}}